Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Engelhardt

Showing results (121-130 of 151) with videos related to

Pageof 16
Sort By:
Hypertension (Dallas, Tex. : 1979)|July 19, 2017
Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney InjuryAdam E Mullick, Steve T Yeh, Mark J Graham, et al.
Zoonoses and Public Health|March 16, 2007
Generalized fatal Cowpox virus infection in a cat with transmission to a human contact caseC Schulze, M Alex, H Schirrmeier, et al.
Toxicologic Pathology|January 19, 2022
Antisense Oligonucleotide-Related Macrovesicular Vacuolation of Hippocampal Neurons in Nonhuman PrimatesMartin Lamb, Jeffery A Engelhardt, Branka Grubor, et al.
Rheumatology International|January 1, 1996
99m-Tc-HMPAO-SPECT in diagnosis of early cerebral vasculitisS Meusser, A Rubbert, B Manger, et al.
Nucleic Acid Therapeutics|January 16, 2024
Safety and Tolerability of GalNAc<sub>3</sub>-Conjugated Antisense Drugs Compared to the Same-Sequence 2'-<i>O</i>-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial DataBrenda F Baker, Shuting Xia, Wesley Partridge, et al.
Regulatory Toxicology and Pharmacology : RTP|May 14, 2013
Calcium lignosulphonate: re-evaluation of relevant endpoints to re-confirm validity and NOAEL of a 90-day feeding study in ratsAnette Thiel, William Braun, Maurice G Cary, et al.
Physical Therapy|August 1, 1996
Work-related musculoskeletal disorders among physical therapistsB E Bork, T M Cook, J C Rosecrance, et al.
Nucleic Acid Therapeutics|April 24, 2023
Complement C3d/C4d Deposition on Platelets Correlates with 2'-O-Methoxyethyl Antisense Oligonucleotide-Induced Thrombocytopenia in MonkeysLijiang Shen, Andrea Wong, Satoru Oneda, et al.
Toxicologic Pathology|January 29, 2011
Industry-contract research organization pathology interactions: a perspective of contract research organizations in producing the best quality pathology reportSylvie J Gosselin, Bernard Palate, George A Parker, et al.
Nucleic Acid Therapeutics|May 4, 2016
Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense OligonucleotideLijiang Shen, Jeffrey A Engelhardt, Gene Hung, et al.
Pageof 16

Showing results (121-130 of 151) with videos related to

Sort By:
Pageof 16
Hypertension (Dallas, Tex. : 1979)|July 19, 2017
Blood Pressure Lowering and Safety Improvements With Liver Angiotensinogen Inhibition in Models of Hypertension and Kidney InjuryAdam E Mullick, Steve T Yeh, Mark J Graham, et al.
Zoonoses and Public Health|March 16, 2007
Generalized fatal Cowpox virus infection in a cat with transmission to a human contact caseC Schulze, M Alex, H Schirrmeier, et al.
Toxicologic Pathology|January 19, 2022
Antisense Oligonucleotide-Related Macrovesicular Vacuolation of Hippocampal Neurons in Nonhuman PrimatesMartin Lamb, Jeffery A Engelhardt, Branka Grubor, et al.
Rheumatology International|January 1, 1996
99m-Tc-HMPAO-SPECT in diagnosis of early cerebral vasculitisS Meusser, A Rubbert, B Manger, et al.
Nucleic Acid Therapeutics|January 16, 2024
Safety and Tolerability of GalNAc<sub>3</sub>-Conjugated Antisense Drugs Compared to the Same-Sequence 2'-<i>O</i>-Methoxyethyl-Modified Antisense Drugs: Results from an Integrated Assessment of Phase 1 Clinical Trial DataBrenda F Baker, Shuting Xia, Wesley Partridge, et al.
Regulatory Toxicology and Pharmacology : RTP|May 14, 2013
Calcium lignosulphonate: re-evaluation of relevant endpoints to re-confirm validity and NOAEL of a 90-day feeding study in ratsAnette Thiel, William Braun, Maurice G Cary, et al.
Physical Therapy|August 1, 1996
Work-related musculoskeletal disorders among physical therapistsB E Bork, T M Cook, J C Rosecrance, et al.
Nucleic Acid Therapeutics|April 24, 2023
Complement C3d/C4d Deposition on Platelets Correlates with 2'-O-Methoxyethyl Antisense Oligonucleotide-Induced Thrombocytopenia in MonkeysLijiang Shen, Andrea Wong, Satoru Oneda, et al.
Toxicologic Pathology|January 29, 2011
Industry-contract research organization pathology interactions: a perspective of contract research organizations in producing the best quality pathology reportSylvie J Gosselin, Bernard Palate, George A Parker, et al.
Nucleic Acid Therapeutics|May 4, 2016
Effects of Repeated Complement Activation Associated with Chronic Treatment of Cynomolgus Monkeys with 2'-O-Methoxyethyl Modified Antisense OligonucleotideLijiang Shen, Jeffrey A Engelhardt, Gene Hung, et al.
Pageof 16